Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers

International Journal of Molecular Medicine

Volumn 28, Issue 3, 2011, Pages 327-336

  Mutalib, Nurul Syakima Ab ^a   Yoke Kqueen, Cheah ^a   Rahman, Sabariah Abdul ^a   Sidik, Shiran Mohd ^a   Singh, Avatar Singh Mohan ^b   Learn Han, Lee ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Taiping Hospital   (Malaysia)

Author keywords

Head and neck cancers; In silico analysis; Microarray; microRNA; Quantitative reverse transcription PCR

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALAYSIA; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALAYSIA; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; YOUNG ADULT;

EID: 79959949313     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.714     Document Type: Article

References (55)

1. Ragin CCR, Modugno F and Gollin SM: The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 86: 104-114, 2007.
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG and Edwards BK (eds). SEER Cancer Statistics Review 1975-2007 National Cancer Institute. Bethesda, MD, 2010.
3. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
4. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4 199-227, 2009.
5. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993. (Pubitemid 24014542)
6. Wightman B, Ha I and Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862, 1993. (Pubitemid 24014543)
7. Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15: 563-568, 2005.
8. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 50: 377-387, 2009.
9. Cohen EEW, Zhu H, Lingen MW, et al: A feed-forward loop involving protein kinase C alpha and microRNAs regulates tumor cell cycle. Cancer Res 69: 65-74, 2009.
10. Macgregor PF and Squire JA: Application of microarrays to the analysis of gene expression in cancer. Clin Chem 48: 1170-1177, 2002. (Pubitemid 34809821)
11. Gomes CC and Gomez RS: MicroRNA and oral cancer: future perspectives. Oral Oncol 44: 910-914, 2008.
12. Yan J, Burman A, Nichols C, et al: Detection of differential gene expression in brown adipose tissue of hibernating arctic ground squirrels with mouse microarrays. Physiol Genomics 25: 346-353, 2006.
13. Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML and Rajkovic A: Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod 77: 312-319, 2007. (Pubitemid 47173614)
14. Yang H, Kong W, He L, et al: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68: 425-433, 2008. (Pubitemid 351380068)
15. Xie H, Lim B and Lodish HF: MicroRNAs induced during adipogenesis that accelerate fat cell development are down-regulated in obesity. Diabetes 58: 1050-1057, 2009.
16. Pandey P, Brors B, Srivastava PK, Bott A, Boehn SN, Groene HJ and Gretz N: Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 9: 624, 2008.
17. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
18. Kanehisa M, Goto S, Furumichi M, Tanabe M and Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-D360, 2010.
19. -ΔΔCt. Methods 25: 402-408, 2001. (Pubitemid 34164012)
20. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
21. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
22. Iorio MV, Visone R, Di Leva G, et al: MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707, 2007. (Pubitemid 47437445)
23. Ambs S, Prueitt RL, Yi M, et al: Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170, 2008.
24. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M and Hu CX: Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 23: 87-94, 2008. (Pubitemid 350265207)
25. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
26. Luo H, Zhang Z, Zhang X, et al: MicroRNA expression signature in gastric cancer. Chin J Canc Res 21: 74-80, 2009.
27. Ramdas L, Giri U, Ashorn CL, Coombes KR, El-Naggar A, Ang KK and Story MD: miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 31: 642-654, 2009.
28. Lee JW, Choi CH, Choi JJ, et al: Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542, 2008.
29. Roehle A, Hoefig KP Repsilber D, et al: MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 142: 732-744, 2008.
30. Mattie MD, Benz CC, Bowers J, et al: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
31. Gee HE, Camps C, Buffa FM, et al: Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116: 2148-2158, 2010.
32. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
33. Avissar M, Christensen BC, Kelsey KT and Marsit CJ: MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15: 2850-2855, 2009.
34. Cervigne NK, Reis PP, Machado J, et al: Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18: 4818-4829, 2009.
35. Karube Y, Tanaka H, Osada H, et al: Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115, 2005. (Pubitemid 40425386)
36. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T and Hammond SM: Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207, 2006.
37. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
38. Liang Y, Ridzon D, Wong L and Chen C: Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 12: 8, 2007.
39. Rosenfeld N, Aharonov R, Meiri E, et al: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26: 462-469, 2008. (Pubitemid 351501813)
40. Calin GA and Croce CM: MicroRNA signatures in human cancers (Review). Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
41. Kozaki K, Imoto I, Mogi S, Omura K and Inazawa J: Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105, 2008. (Pubitemid 351521781)
42. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP and Wei WI: Mature miR-184 as potential oncogenic microrna of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592, 2008.
43. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST and Ghoshal K: TGFβ-mediated up-regulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29: 1787-1797, 2010.
44. Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z and You Y: hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193, 2008.
45. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005. (Pubitemid 41439922)
46. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T and Si J: Downregulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 44: 556-561, 2009.
47. Nakada C, Matsuura K, Tsukamoto Y, et al: Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol 216: 418-427, 2008.
48. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Cancer Res 69: 1135-1142, 2009.
49. Cao P, Deng Z, Wan M, et al: MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta. Mol Cancer 9: 108, 2010.
50. Fassan M, Baffa R, Palazzo JP, et al: MicroRNA expression profiling of male breast cancer. Breast Cancer Res 11: R58, 2009.
51. Bartel DP, Lee R and Feinbaum R: MicroRNAs: genomics, bio-genesis, mechanism, and function genomics: the miRNA genes. Cell 116: 281-297, 2004.
52. Kim VN MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385, 2005.
53. Khvorova A, Reynolds A and Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell 115: 209-216, 2003. (Pubitemid 37329584)
54. Schwarz DS, Hutvágner G, Du T, Xu Z, Aronin N and Zamore PD: Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208, 2003. (Pubitemid 37329583)
55. Gold KA, Lee HY and Kim ES: Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 115: 922-935, 2009.